The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-672

My overall thought on options is that holders will be looked after in the event of any sale - how exactly, well that's a different question.

Firstly, board members, and MT, are option holders - self interest is important.

Secondly, IMO, MT has been showing his colours in the way he has been looking after LTH's since day 1. The opportunity to re-purchase loyalty options at .005c was a masterstroke, and a source of significant wealth for many here.

Thirdly, Clear, honest ( and as specific as he legally can be ) communication. Building trust quickly ... if he says targetting >$2B ... I have little reason to doubt him ( targeting is different to achieving of course ).

Fourthly, I think MT has become/is , the perfect counterbalance to RA.

....

I had a look at the ResApp Scheme of sale to get a feel for happened there.

From what I can see :

Essentially, option holders were offered a cash payment commensurate with the option price vs sale price ( some options were at a conversion price higher than the sale price, so in effect had no value. If the conversion price was lower than the sale price, then the difference between sale price & the conversion price was offered as a cash payment ).

Option holders also had the chance to convert before the record date, if they elected to forgo the cash payment.